Zavesca Capsule
Product Images NDC 66215-201

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Zavesca (NDC 66215-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actelion Pharmaceuticals Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zavesca 01)

Chemical structure diagram of miglustat, the active ingredient in Zavesca. The image shows a hexagonal ring with various hydroxyl (-OH) groups and a nitrogen atom, representing the molecular structure of miglustat.*

FDA Label Image

Principal Display Panel (90 Capsule Carton)

Packaging label for Zavesca 100 mg capsules (miglustat), manufactured by Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company. The label states the active ingredient strength, capsule form, oral route, and package contents of 90 capsules in blister cards. Storage and inactive ingredient information are provided, along with a note that the package is not child resistant. The label includes barcodes and Janssen logos.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.